financetom
Business
financetom
/
Business
/
POCO X2 launching on February 4 with high refresh rate screen
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
POCO X2 launching on February 4 with high refresh rate screen
Jan 28, 2020 3:47 AM

Chinese handset maker POCO, which Xiaomi spinned off as a standalone brand earlier this month, is ready to launch its POCO X2 smartphone on February 4 with a high refresh rate and liquid cooling technology.

An image showing the bottom of the phone seems to suggest the POCO X2 will be similar to the Redmi K30 that Xiaomi had announced last month, Android Central reported on Monday.

POCO has also gone ahead and set up a dedicated website mentioning the details of the launch, which reveals a few key details about the upcoming smartphone.

As per the website, the POCO X2 will feature a high refresh rate display, liquid cooling, and, most likely, a Sony IMX 686 primary sensor.

While it remains to be seen if the two phones will be identical in terms of tech specs, they are likely to be very similar in most areas. On the software front, the POCO X2 is expected to run "MIUI for POCO" out of the box, based on Android 10 operatig system (OS), the report added.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
MultiPlan Partners With J2 Health
MultiPlan Partners With J2 Health
Jan 10, 2025
01:25 PM EST, 01/10/2025 (MT Newswires) -- MultiPlan ( MPLN ) said Friday it has partnered with privately held J2 Health to work on customized products for insurers and health plan operators. MultiPlan ( MPLN ) said clients are expected to benefit from the new alliance through improved network configuration, transparency and analytics, with J2's software platform also working to...
Why Calidi Biotherapeutics (CLDI) Stock Is Down 30%
Why Calidi Biotherapeutics (CLDI) Stock Is Down 30%
Jan 10, 2025
Calidi Biotherapeutics Inc ( CLDI ) shares are trading lower by 32% to 92 cents during Friday’s session after the company priced its public offering of 5 million shares of common stock at $0.85 per share, aiming to raise approximately $4.25 million in gross proceeds. The offering is set to close on January 10, pending customary closing conditions. Ladenburg Thalmann...
Crinetics Shares Fall After Reporting 'Positive' Phase 2 Results for Congenital Adrenal Hyperplasia Treatment
Crinetics Shares Fall After Reporting 'Positive' Phase 2 Results for Congenital Adrenal Hyperplasia Treatment
Jan 10, 2025
01:19 PM EST, 01/10/2025 (MT Newswires) -- Crinetics Pharmaceuticals ( CRNX ) shares were down more than 12% Friday after the company reported positive topline results from a phase 2 trial of investigational compound atumelnant for treating classic congenital adrenal yyperplasia, or CAH, and adrenocorticotropic hormone, or ACTH-dependent Cushing's syndrome. The study, which included 28 patients across three dose groups,...
Ecolab Well-Positioned for Future Growth, Faces Short-Term Challenges, RBC Says
Ecolab Well-Positioned for Future Growth, Faces Short-Term Challenges, RBC Says
Jan 10, 2025
01:21 PM EST, 01/10/2025 (MT Newswires) -- Ecolab ( ECL ) is expected to achieve stable volume and pricing growth during 2025, keeping the cleaning supplies company on track for moderate improvement, though it may still fall slightly short of consensus expectations for the next 12 months, analysts at RBC Capital Markets said in an earnings preview. For Q4, RBC...
Copyright 2023-2026 - www.financetom.com All Rights Reserved